Correlation Between Spyre Therapeutics and Destiny Tech100

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Destiny Tech100 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Destiny Tech100 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Destiny Tech100, you can compare the effects of market volatilities on Spyre Therapeutics and Destiny Tech100 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Destiny Tech100. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Destiny Tech100.

Diversification Opportunities for Spyre Therapeutics and Destiny Tech100

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Spyre and Destiny is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Destiny Tech100 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Destiny Tech100 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Destiny Tech100. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Destiny Tech100 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Destiny Tech100 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Destiny Tech100

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Destiny Tech100. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 2.39 times less risky than Destiny Tech100. The stock trades about -0.02 of its potential returns per unit of risk. The Destiny Tech100 is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,410  in Destiny Tech100 on September 3, 2024 and sell it today you would earn a total of  2,647  from holding Destiny Tech100 or generate 187.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  Destiny Tech100

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Destiny Tech100 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Destiny Tech100 are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Destiny Tech100 showed solid returns over the last few months and may actually be approaching a breakup point.

Spyre Therapeutics and Destiny Tech100 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and Destiny Tech100

The main advantage of trading using opposite Spyre Therapeutics and Destiny Tech100 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Destiny Tech100 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Destiny Tech100 will offset losses from the drop in Destiny Tech100's long position.
The idea behind Spyre Therapeutics and Destiny Tech100 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities